These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29755679)

  • 1. microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
    Pardini B; Cordero F; Naccarati A; Viberti C; Birolo G; Oderda M; Di Gaetano C; Arigoni M; Martina F; Calogero RA; Sacerdote C; Gontero P; Vineis P; Matullo G
    Oncotarget; 2018 Apr; 9(29):20658-20669. PubMed ID: 29755679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
    Moisoiu T; Dragomir MP; Iancu SD; Schallenberg S; Birolo G; Ferrero G; Burghelea D; Stefancu A; Cozan RG; Licarete E; Allione A; Matullo G; Iacob G; Bálint Z; Badea RI; Naccarati A; Horst D; Pardini B; Leopold N; Elec F
    Mol Med; 2022 Apr; 28(1):39. PubMed ID: 35365098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.
    Matullo G; Naccarati A; Pardini B
    Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades.
    Sabo AA; Birolo G; Naccarati A; Dragomir MP; Aneli S; Allione A; Oderda M; Allasia M; Gontero P; Sacerdote C; Vineis P; Matullo G; Pardini B
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32527011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
    Oto J; Plana E; Fernández-Pardo Á; Cana F; Martínez-Sarmiento M; Vera-Donoso CD; España F; Medina P
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33105660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease.
    Li AL; Chou CY; Chen CL; Wu KL; Lin SC; Chen HC; Wang MC; Chang CC; Hsu BG; Wu MS; Ma N; Huang CC
    Front Med (Lausanne); 2021; 8():726214. PubMed ID: 34660637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
    Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A
    Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study.
    Bansal A; Hong X; Lee IH; Krishnadath KK; Mathur SC; Gunewardena S; Rastogi A; Sharma P; Christenson LK
    Clin Transl Gastroenterol; 2014 Dec; 5(12):e65. PubMed ID: 25502391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
    Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.